Rhoen Klinikum AG (RHK) PT Set at €26.50 by Berenberg Bank
Rhoen Klinikum AG (ETR:RHK) has been assigned a €26.50 ($31.55) price target by equities researchers at Berenberg Bank in a research note issued to investors on Wednesday. The brokerage presently has a “neutral” rating on the stock.
A number of other research firms also recently weighed in on RHK. Commerzbank Ag set a €25.00 ($29.76) target price on Rhoen Klinikum AG and gave the company a “neutral” rating in a research report on Monday. DZ Bank AG reiterated a “sell” rating on shares of Rhoen Klinikum AG in a research report on Tuesday, August 29th. Independent Research GmbH set a €28.00 ($33.33) target price on Rhoen Klinikum AG and gave the company a “neutral” rating in a research report on Monday, August 14th. Credit Suisse Group set a €24.40 ($29.05) target price on Rhoen Klinikum AG and gave the company a “sell” rating in a research report on Friday, August 4th. Finally, Deutsche Bank AG set a €21.00 ($25.00) target price on Rhoen Klinikum AG and gave the company a “neutral” rating in a research report on Friday, August 4th. Three investment analysts have rated the stock with a sell rating and six have issued a hold rating to the company. The company has an average rating of “Hold” and an average price target of €24.06 ($28.65).
Rhoen Klinikum AG (ETR RHK) opened at 27.959 on Wednesday. The firm’s 50 day moving average price is €27.56 and its 200-day moving average price is €26.35. Rhoen Klinikum AG has a one year low of €22.91 and a one year high of €28.67. The company has a market capitalization of €1.87 billion and a PE ratio of 436.859.
Rhoen Klinikum AG Company Profile
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.
Receive News & Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related companies with MarketBeat.com's FREE daily email newsletter.